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OBJECTIVES We sought to explore the relative contributions of ventricular remodeling and myocardial
dysfunction to heart failure in pressure overload hypertrophy (POH).
BACKGROUND The mechanism that underlies heart failure in POH is adverse left ventricular (LV) chamber
remodeling or decreased myocardial function, or a combination of these.
METHODS Twenty weeks after suprarenal aortic banding in rats, animals with POH were classified as
those with heart failure (POH-HF) or those with no heart failure (POH-NHF). The LV
chamber and myocardial systolic and diastolic functions were determined from in vivo and ex
vivo experiments.
RESULTS The LV mass was similar in both POH groups. Chamber remodeling in the POH-HF group
was characterized by marked LV enlargement with a normal relative wall thickness (eccentric
remodeling), whereas remodeling in the POH-NHF group was characterized by a normal
chamber size and increased relative wall thickness (concentric remodeling). The LV systolic
function, as determined in vivo from the end-systolic pressure–diameter relationship and ex
vivo from the pressure–volume relationship, was lower in the POH-HF group than in the
POH-NHF and sham-operated control groups. In contrast, myocardial function was similar
in both POH groups, as determined in vivo from the stress–midwall fractional shortening
relationship and myocardial systolic stiffness, and ex vivo from the slope of the LV systolic
stress–strain relationship. The diastolic chamber stiffness constant was lower in the POH-HF
group than in the POH-NHF group, but the myocardial stiffness constant was similar in the
two POH groups.
CONCLUSIONS The two POH groups differed primarily in their remodeling process, which led to a
chronically compensated state in one group and to heart failure in the other. Hence, heart
failure in POH is more closely related to deleterious LV remodeling than to depressed
myocardial function. (J Am Coll Cardiol 2002;39:664–71) © 2002 by the American
College of Cardiology
Left ventricular (LV) failure in pressure overload hypertro-
phy (POH) is heralded by a decrement in LV systolic and
diastolic function (1,2). The mechanism that is likely to
underlie such decompensation is adverse LV chamber re-
modeling (3–5) or decreased myocardial contractile function
(6–10), or a combination of these (4,7). Cohn (5,11) has
suggested that chronic structural remodeling of the LV may
be the major impetus to heart failure and that such remod-
eling, not primary myocardial contractile dysfunction, is the
principal contributor to the failure of the heart as a pump.
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This notion is supported by the observation that post-
infarction remodeling with global LV dysfunction has been
shown to occur with little or no myocyte contractile abnor-
malities (12). However, the relative contributions of detri-
mental remodeling and depressed myocardial contractile
function to pump failure in POH are unknown. If LV
remodeling is the dominant factor, prevention or reversal of
such a detrimental process becomes an important therapeu-
tic goal (4,5). Therefore, we studied the functional proper-
ties of the LV chamber and the mechanical properties of the
myocardium in compensated and failing rats with POH,
and we tested the hypothesis that LV failure in POH is
predominantly related to deleterious LV remodeling rather
than depressed myocardial function.
METHODS
Experiments were performed in accordance with the Guide
for the Care and Use of Laboratory Animals (National
Institutes of Health, publication no. 86-23, 1996). The
protocol was approved by the Animal Research Committee
of the University of Massachusetts Medical School. Male
Sprague-Dawley rats (weight 200 g) were subjected to either
suprarenal aortic banding or a sham operation, as previously
described (13). Of the 200 banded rats, 88 animals survived
for 20 weeks. Eight rats were excluded, because their LV
weights were similar to those of the control group (n  30).
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Of the remaining 80 animals, 39 rats had a lung weight/
body weight ratio 2 SD above the mean for the control
group and were classified as POH with heart failure (POH-
HF). The rest of the rats were classified as POH with no
failure (POH-NHF). Twenty weeks after the operation, the
control, POH-HF and POH-NHF rats were randomly
used for either groups’ in vivo or ex vivo experiments.
In vivo studies. The rats were anesthetized, and their
carotid blood pressure (BP) was measured as previously
described (13). Echocardiography was performed from be-
low using a 7.5-MHz transducer and a Hewlett-Packard
Sonos 1500 sector scanner, as outlined previously (13).
After baseline BP and echocardiographic recordings were
obtained, the load was manipulated by slowly infusing
angiotensin II (5 nmol/liter, dissolved in 1 ml of normal
saline) through the carotid catheter over a 10- to 20-s
period. Once the BP had stabilized, normal saline was
infused (0.5 to 3 ml) to determine whether maximal peak
systolic BP had been attained. Blood was then withdrawn
(0.5 to 1 ml per 5 min period to a maximum of 6 ml) to
decrease the load. Echocardiographic dimensions were ob-
tained at the maximal systolic BP and when hemodynamic
measurements were stable during blood withdrawal. Data
were excluded if peak systolic pressure was 120 mm Hg.
The LV internal dimensions and wall thickness were mea-
sured according to the American Society for Echocardio-
graphy’s leading edge method (14). Measurements were
made from three consecutive beats, and relative wall thick-
ness and fractional shortening were calculated as previously
described (13).
LEFT VENTRICULAR CHAMBER FUNCTION. In vivo LV sys-
tolic chamber function was evaluated by constructing the
end-systolic pressure–dimension relationship from a range
of pressure and diameter coordinates obtained during the
loading interventions.
MYOCARDIAL FUNCTION. In vivo myocardial systolic
function was assessed by constructing LV midwall stress–
shortening and end-systolic stress–strain (stiffness) relation-
ships. Midwall fractional shortening (FSmw) and end-
systolic stress were derived as previously described (15,16).
To compare shortening at a similar stress value, FSmw was
calculated at a stress rate of 75 g·cm2 from the slope and
intercepts of these relationships. The end-systolic stress–
strain relationship was calculated as previously described
(17). Because end-systolic diameters were not available at
0 mm Hg, we adopted the approach that is commonly used
in isolated papillary muscle studies, where strain is deter-
mined as a fraction of the length of the muscle strip (in our
case, the end-systolic diameter as a surrogate for length),
which achieves maximal tension (stress).
Ex vivo studies. The isolated, perfused heart preparation
used in this study was previously described by Chung et al.
(13). After the rats were anesthetized, their hearts were
excised, rinsed and weighed in ice-cold physiologic saline
solution. The hearts were then perfused at a flow rate
adjusted to achieve an approximate flow of 12 ml/min per g
heart weight, which was kept constant throughout the
experiment. Coronary perfusion pressure was monitored
throughout the experiment. The hearts were paced at 300
beats/min. A thin-walled latex balloon with a capacity
beyond the maximal lumen capacity of the LV was then
inserted into the LV cavity through the left atrium and
attached to a Statham P23 Db transducer. The volume of
the balloon wall was assessed using a water displacement
technique. A micromanipulator was used to gradually in-
crease the LV volumes. The LV diastolic and developed
pressures were recorded with every increment in volume, so
that a range of pressure–volume data were obtained.
SYSTOLIC AND DIASTOLIC LV CHAMBER FUNCTION. Ex
vivo LV systolic and diastolic chamber functions were
assessed by constructing the systolic (developed) and dia-
stolic pressure–volume relationships from developed and
diastolic pressure–volume data coordinates.
SYSTOLIC AND DIASTOLIC MYOCARDIAL FUNCTION. Ex
vivo myocardial function was assessed by constructing the
developed systolic stress–strain and diastolic stress–strain
relationships. Developed systolic stress and strain were
calculated by using previously described equations (18),
assuming a thick-walled, spherical LV geometry. Diastolic
myocardial stiffness was calculated using previously de-
scribed formulae (19).
Myocardial collagen. Samples of LV tissue from all rats
were weighed and stored at 80°C for hydroxyproline
analysis. The myocardial hydroxyproline concentration was
determined by using the method of Stegemann and Stalder
(20).
Data analysis. The slopes of pressure–dimension, systolic
and diastolic pressure–volume, stress–shortening and end-
systolic and end-diastolic stress–strain relationships of each
animal were determined by linear regression analysis. Dif-
ferences in LV geometry, hemodynamic variables and bio-
chemical variables between the groups were assessed using
one-factor analysis of variance, followed by Tukey’s post hoc
test. A p value 0.05 was considered significant. All data
are expressed as the mean value  SEM.
Abbreviations and Acronyms
BP  blood pressure
FSmw  midwall fractional shortening
LV  left ventricular
POH  pressure overload hypertrophy
POH-HF  pressure overload hypertrophy with heart
failure
POH-NHF  pressure overload hypertrophy with no
heart failure
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RESULTS
Blood pressure and heart and lung weights. Systolic and
diastolic BPs were elevated in both POH groups, with
pressures being higher in the POH-NHF group than in the
POH-HF group (Table 1). The LV weight increased to a
similar extent in both POH groups. However, right ven-
tricular weight was greater in the POH-HF group than in
the POH-NHF and control groups. Similarly, the lungs of
the POH-HF group weighed twofold more than those of
the other two groups, consistent with pulmonary congestion
(Tables 1 and 2). Unlike the in vivo POH-HF group, the
body weight of the ex vivo POH-HF group was lower than
that of the control and POH-NHF groups.
Geometric and interstitial remodeling. In response to
chronic pressure overload, the POH-NHF group remod-
eled concentrically, whereas the POH-HF group remodeled
eccentrically (Table 1). Consequently, the relative wall
thickness was lower and the end-systolic wall stress was
higher in the POH-HF group than in the POH-NHF
group (Table 1). Myocardial total hydroxyproline concen-
trations were higher in the POH-HF groups of both in vivo
and ex vivo experiments than in the control and POH-NHF
groups (Tables 1 and 2).
Systolic and diastolic LV chamber function. The
POH-HF group was characterized by a decline in fractional
endocardial shortening (Table 1), as well as a rightward
shift and a decrease in the slope of both the pressure–
dimension and pressure–volume relationships, as compared
with the control and POH-NHF groups (Figs. 1 and 2,
Table 3). The changes in the pressure–volume relationship
could not be attributed to differences in coronary flow
(Table 2).
In response to angiotensin II infusions, fractional endo-
cardial shortening decreased to a similar extent in the
control and POH-NHF groups (34.2  0.9% and 35.9 
2%, respectively). The LV end-systolic stress increased to
levels comparable to those obtained in the POH-HF group
under baseline conditions (stress measured in g·cm2: 83 
3 [control group] vs. 82  4 [POH-NHF group]) (Table
1). However, fractional endocardial shortening in both the
control and POH-NHF groups was still significantly
greater than that seen in the POH-HF group before the
infusion of angiotensin II (28.5  1.0%, p  0.01). Thus,
at common levels of systolic stress, LV chamber function
was lower in the POH-HF group than in the control and
POH-NHF groups.
Table 1. In Vivo Data in Control Rats and Rats With Pressure Overload Hypertrophy With or
Without Pulmonary Congestion
Control Group
(n  18)
POH-NHF
Group (n  16)
POH-HF
Group (n  18)
Systolic BP (mm Hg) 158  4 215  6* 185  8*†
Diastolic BP (mm Hg) 105  3 125  2* 112  5†
Body weight (g) 433  10 438  12 456  10
LV weight (g) 1.12  0.04 1.63  0.06* 1.73  0.06*
LV weighti 2.61  0.11 3.73  0.13* 3.82  0.13*
RV weight (g) 0.22  0.01 0.28  0.02* 0.36  0.02*†
Lung weight (g) 2.12  0.07 2.17  0.09 4.55  0.33*†
LV end-systolic stress (gcm2) 60.4  5.1 62.5  8.2 83.3  7.5*†
LVEDD (mm) 8.59  0.17 8.80  0.25 10.41  0.31*†
LVESD (mm) 5.18  0.16 5.28  0.31 7.25  0.27*†
LV relative wall thickness 0.36  0.02 0.47  0.03* 0.41  0.02†
FSendo (%) 39.7  1.5 40.6  2.1 28.5  1.0*†
Hydroxyproline (g/mg per dry LV weight) 3.98  0.20 4.33  0.31 5.47  0.36*†
*p  0.05 versus control group; †p  0.05 versus POH-NHF group. Data are presented as the mean value  SEM.
BP  blood pressure; FSendo  fractional shortening at the endocardium; LV  left ventricular; LV weighti  LV
weight/100 per body weight 103; LVEDD LV end-diastolic diameter; LVESD LV end-systolic diameter; POH-HF
pressure overload hypertrophy with heart failure; POH-NHF pressure overload hypertrophy with no heart failure; RV right
ventricular.
Table 2. Ex Vivo Data in Control Rats and Rats With Pressure Overload Hypertrophy With or
Without Pulmonary Congestion
Control Group
(n  12)
POH-NHF
Group (n  25)
POH-HF
Group (n  21)
Body weight (g) 471  11 449  8 416  10*†
LV weight (g) 1.21  0.05 1.72  0.04* 1.79  0.04*†
LV weighti 2.55  0.06 3.84  0.07* 4.33  0.09*†
RV weight (g) 0.28  0.02 0.30  0.01 0.39  0.03*†
Lung weight (g) 1.93  0.06 1.96  0.05 4.04  0.32*†
Hydroxyproline (g/mg per dry LV weight) 3.43  0.14 4.17  0.19 5.07  0.21*†
Coronary flow (ml/min per g wet heart weight) 12.1  1.9 12.9  1.2 12.1  1.9
*p  0.05 versus control group. †p  0.05 versus POH-NHF group. Data are presented as the mean value  SEM.
Abbreviations as in Table 1.
666 Norton et al. JACC Vol. 39, No. 4, 2002
Ventricular Remodeling in Pressure Overload Hypertrophy February 20, 2002:664–71
The diastolic LV chamber stiffness constant (k) was lower
in the POH-HF group than in the control and POH-NHF
groups (Table 3, Fig. 3). The intercept of the diastolic
pressure–volume relationship shifted from 0.23  0.006 ml
in the control group and 0.24  0.007 ml in the POH-
NHF group to 0.35  0.009 ml in the POH-HF group
(p  0.001) (Fig. 3).
Systolic and diastolic myocardial function. In contrast to
the differences in LV systolic chamber function noted
between the POH-HF and POH-NHF groups, myocardial
function was similar in the two POH groups (Figs. 4–6,
Table 3). Both POH groups exhibited a nonsignificant
depression of the stress–shortening relationship; approxi-
mately one-third of the stress–FSmw values for both POH
groups fell below the lower 95% confidence limits of the
control group (data not shown). Although there was no
difference in the stress–strain (stiffness) relationship, as
determined from the in vivo data, both POH groups
exhibited a rightward shift and a decrease in the slope of the
myocardial stress–strain relationship (Figs. 5 and 6). Thus,
myocardial function appears to be normal to depressed in
both POH groups; all three indexes indicate that there was
no difference in myocardial function between the two POH
groups. Similarly, there was no difference in the diastolic
myocardial stiffness constant (k) between the POH-HF and
POH-NHF groups (Table 3, Fig. 3).
DISCUSSION
The major finding of the present study is that heart failure
in POH is more closely related to deleterious LV remodel-
ing than to depressed myocardial contractile function. In
contrast to the concentric hypertrophic response seen in the
POH-NHF group, the POH-HF group exhibited chamber
Figure 1. Left ventricular systolic function in rats with pressure overload
hypertrophy (POH). The in vivo pressure–dimension relationship in the
pressure overload hypertrophy with heart failure (POH-HF) and pressure
overload hypertrophy with no heart failure (POH-NHF) groups exhibits a
progressive rightward shift that is most pronounced in the POH-HF group
(top). The slope of this relationship (Ees) in the POH-HF group is
significantly lower (25%) than that in the control group (bottom),
although the small reduction (10%) in the POH-NHF group is not
significantly less. *p  0.05 vs. control and POH-NHF groups. CON 
sham-operated control group; ESP  end-systolic pressure.
Figure 2. Left ventricular systolic function in rats with POH. The ex vivo
pressure–volume relationship in the POH-HF and POH-NHF groups
exhibits a progressive rightward shift that is most prominent in the group
with heart failure (top). The slope of this relationship (E) is significantly
lower (50%) in the POH-HF group than in the control group, although
the small reduction (15%) in the POH-NHF group is not significantly
less. *p  0.05 vs. control and POH-NHF groups. LVP  left ventricular
pressure; V  volume; other abbreviations as in Figure 1.
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enlargement, lower relative wall thickness, increased systolic
wall stress and reduced systolic shortening. However, the
two POH groups did not show significant differences in
myocardial mass or myocardial contractile function. There-
fore, it appears that the two POH groups differed primarily
in the remodeling process, which led to a chronically
compensated state in one group and to heart failure in the
other (Table 4).
Table 3. Left Ventricular Chamber and Myocardial Systolic and Diastolic Function in the
Control and Pressure Overload Hypertrophy Groups
Control
Group
POH-NHF
Group
POH-HF
Group
LV chamber function
In vivo systolic elastance (Ees; mm Hg/mm) 34  3 31.5  3 26  1.5*†
Ex vivo systolic elastance (Ees; mm Hg/ml) 598  48 493  41 291  9*†
Ex vivo diastolic chamber stiffness constant
(k; gcm2)
18.1  1.3 18.2  1.5 13.2  1.0*†
Myocardial function
In vivo stress–shortening relation (FSmw 75%) 19.3  1.1 16.6  5.4 18.1  1.5
In vivo systolic myocardial stiffness (gcm2) 327  39 258  27 327  18
Ex vivo stress–strain relation (En) 687  23 515  5* 479  14*
Ex vivo diastolic myocardial stiffness constant
(k; gcm2)
39  3.6 42  2.2 44  2.4
*p  0.05 vs. control group. †p  0.05 vs. POH-NHF group. Data are presented as the mean value  SEM.
FSmw 75-fractional midwall shortening at a common stress of 75 gcm
2; other abbreviations as in Table 1.
Figure 3. Left ventricular and myocardial diastolic function in rats with POH.
A reduced diastolic chamber stiffness is noted for the POH-HF group (A),
although there is a trend (p  0.25) for myocardial stiffness to increase in the
same group, as compared with the control and POH-NHF groups (B).
LVED(P) or (V)  left ventricular end-diastolic (pressure) or (volume).
Abbreviations as in Figure 1.
Figure 4. Myocardial systolic function in rats with POH. The in vivo stress
()–shortening (FSmw) relationship exhibits a trend toward depression in
both POH groups (top). However, at a common stress of 75 g·cm2,
shortening in both POH groups was similar to that of the control group
(bottom). Thus, myocardial function in the POH-HF and POH-NHF
groups was similar. Abbreviations as in Figure 1.
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Influence of geometry on the assessment of LV chamber
and myocardial function. In these studies, we assessed LV
function using measurements taken at the endocardial
surface (e.g., dimension, volume, shortening at the endo-
cardial surface). Such variables reflect LV (chamber) func-
tion. To overcome the limitations of using functional
variables that are influenced by chamber geometry, we
assessed myocardial function with normalized midwall
stress–shortening and stress–strain relationships using in
vivo and ex vivo techniques (Figs. 3 and 4) (15,16,21).
The assessment and comparison of ventricular and myo-
cardial function is complicated by the distinctly different
remodeling patterns in the two POH groups. Eccentric
geometry in the POH-HF group was accompanied by
major abnormalities in ventricular function, in combination
with what appears to be normal to depressed myocardial
function. It is therefore possible that an earlier stage of
remodeling could be accompanied by depressed chamber
function and preserved myocardial function. In contrast,
concentric remodeling with greater relative wall thickness is
accompanied by normal ventricular chamber function and
myocardial function, similar to that seen in the POH-HF
group (22). These observations dictate the utilization of
indexes that reflect LV chamber function, in combination
with those that reflect the functional properties of the
myocardium.
Left ventricular remodeling versus myocardial dysfunc-
tion. The findings in this study did not suggest that
myocardial contractile function was normal in the POH
groups. The in vivo stress–shortening data suggest a small
functional decrement in the two POH groups (p  NS).
The ex vivo stress–strain data indicate significant myocardial
depression in both POH groups, as compared with the
control group. These findings are concordant with a large
body of data on myocardial contractile function in the
hypertrophic myocardium (6–10). Thus, myocardial func-
tion, though probably depressed, was remarkably similar in
the two POH groups, despite major differences in ventric-
ular geometry and chamber function.
In agreement with the aforementioned conclusions was
Figure 5. Myocardial systolic function in rats with pressure overload
hypertrophy (POH). The in vivo left ventricular end-systolic (LVES)
stress–strain (systolic stiffness) relationship was similar in both POH
groups and was not different from that of the control group. ESD 
end-systolic diameter; other abbreviations as in Figure 1.
Figure 6. Myocardial systolic function in rats with POH. The ex vivo stress
()–strain relationship exhibits depression in both POH groups (25%
lower than that in the control group) (top). The slope of this relationship
(En) is similar in both POH groups. Myocardial function in the POH-HF
and POH-NHF groups was similar. *p  0.05 vs. control group.
Abbreviations as in Figure 1.
Table 4. Left Ventricular and Myocardial Function in Pressure
Overload Hypertrophy With or Without Heart Failure
POH-NHF POH-HF
LV mass 1 1
LV geometry
End-diastolic diameter N 1
Relative wall thickness 1 N
Fractional shortening N 2
Hydroxyproline concentration N 1
Systolic and diastolic LV chamber
function
In vivo systolic P-D relation N 2
Ex vivo systolic P-V relation N 2
Ex vivo diastolic chamber stiffness N 2
Systolic and diastolic myocardial function
In vivo stress–shortening relation N N
In vivo systolic myocardial stiffness N N
Ex vivo systolic stress–strain relation 2 2
Ex vivo diastolic myocardial stiffness N N
P-D pressure–dimension; P-V pressure–volume; N not different from control
group; 2  decreased; 1  increased; other abbreviations as in Table 1.
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the finding that the diastolic chamber stiffness constant (k)
in the POH-HF group was lower than that seen in the
POH-NHF group. These non-normalized chamber stiff-
ness results are consistent with chamber dilation, and they
do not necessarily represent differences in diastolic myocar-
dial stiffness. Although the diastolic myocardial stiffness
constants tended to be higher in the POH-HF group than
in the POH-NHF group, and hence, may have contributed
to pulmonary congestion, the differences were small and not
statistically significant. These findings parallel those for
systolic chamber and myocardial function. Thus, the systolic
and diastolic properties of the LV chamber differ substan-
tially between the POH-HF and POH-NHF groups,
although those of the myocardium do not.
The myocardial collagen content (hydroxyproline) was
significantly higher in the POH-HF group than in the
POH-NHF group. Because increased collagen content
occurs in response to mechanical overload and participates
in the adaptation process of remodeling (23), an increased
hydroxyproline concentration is probably a marker of an
active remodeling process. These findings support the no-
tion that the hearts of the POH-HF group showed evidence
of more aggressive and detrimental remodeling, as com-
pared with the hearts of the POH-NHF group.
The findings in this study appear to be at odds with the
findings in some other studies of POH (6–9). First, in
contrast to our observations that myocardial contractile
function was similar in the POH groups with and without
heart failure, Conrad et al. (9) demonstrated that active
tension development and shortening velocity of isolated LV
papillary muscles from spontaneously hypertensive rats with
heart failure are depressed, as compared with those variables
from animals without heart failure. Similar conclusions were
reached on the basis of papillary muscle experiments in Dahl
salt-sensitive rats with heart failure (6). Differences in the
animal models used to evaluate the transition to heart failure
in POH may, at least in part, explain these discrepant
findings. For example, myocardial dysfunction in the aging,
spontaneously hypertensive rat is likely to be due to the
combined effects of aging and hypertension, rather than
pressure overload alone. In the model of POH used in our
study, younger animals were used, and these rats had a high
mortality early after the operation (50% died within the
first 4 weeks of aortic banding). Hence, the model in this
study represents a more aggressive pressure overloaded state
in younger rats, which resulted in advanced hypertrophy in
both POH groups. Second, although we showed that heart
failure in POH is closely related to the degree of deleterious
remodeling, Morii et al. (7) suggested that the transition
from compensated hypertrophy to heart failure in Dahl
salt-sensitive rats is due to decreased myocardial contractil-
ity and abnormal ventricular remodeling. These conclusions
were based on the demonstration of a shift in the intercept
and a decrease in the slope of the end-systolic pressure–
volume relationship in failing hearts. However, the pres-
sure–volume relationship of the LV is inherently an expres-
sion of the mechanical behavior of the chamber, rather than
measure of its muscle properties (21).
Conclusions. The remodeling process, which involves
complex molecular and cellular mechanisms, appears to be a
major contributor to the process of decompensation in
POH. The progressive changes in LV volume and shape
associated with eccentric remodeling present a considerable
mechanical disadvantage to the heart and promote worsen-
ing of LV pump function. The increased chamber volume
contributes to increases in systolic wall stress, leading to
afterload mismatch and sustained overload. The resultant
hemodynamic abnormalities activate compensatory neuro-
hormonal mechanisms that, over time, further contribute to
disease progression. Our data and those of Anand et al. (12)
identify reversal of deleterious remodeling as a potential
therapeutic goal in hearts with early evidence of LV cham-
ber enlargement in POH and after myocardial infarction.
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